nodes	percent_of_prediction	percent_of_DWPC	metapath
Terconazole—Dysmenorrhoea—Topotecan—ovarian cancer	0.0254	0.027	CcSEcCtD
Terconazole—Ketoconazole—CYP1B1—ovarian cancer	0.0231	0.373	CrCbGaD
Terconazole—Posaconazole—ABCB1—ovarian cancer	0.021	0.341	CrCbGaD
Terconazole—Asthenia—Altretamine—ovarian cancer	0.0187	0.0199	CcSEcCtD
Terconazole—Dizziness—Altretamine—ovarian cancer	0.0172	0.0183	CcSEcCtD
Terconazole—Toxic epidermal necrolysis—Chlorambucil—ovarian cancer	0.0169	0.0181	CcSEcCtD
Terconazole—Vomiting—Altretamine—ovarian cancer	0.0165	0.0176	CcSEcCtD
Terconazole—Nausea—Altretamine—ovarian cancer	0.0155	0.0165	CcSEcCtD
Terconazole—Pain—Carboplatin—ovarian cancer	0.0154	0.0164	CcSEcCtD
Terconazole—Body temperature increased—Carboplatin—ovarian cancer	0.0142	0.0151	CcSEcCtD
Terconazole—Bronchospasm—Melphalan—ovarian cancer	0.0139	0.0149	CcSEcCtD
Terconazole—Influenza like illness—Paclitaxel—ovarian cancer	0.0129	0.0137	CcSEcCtD
Terconazole—Bronchospasm—Vinorelbine—ovarian cancer	0.0122	0.013	CcSEcCtD
Terconazole—Itraconazole—ABCB1—ovarian cancer	0.0111	0.179	CrCbGaD
Terconazole—Influenza like illness—Docetaxel—ovarian cancer	0.0109	0.0117	CcSEcCtD
Terconazole—Chills—Topotecan—ovarian cancer	0.0104	0.0111	CcSEcCtD
Terconazole—Ill-defined disorder—Topotecan—ovarian cancer	0.00936	0.00998	CcSEcCtD
Terconazole—Malaise—Topotecan—ovarian cancer	0.0091	0.0097	CcSEcCtD
Terconazole—Toxic epidermal necrolysis—Paclitaxel—ovarian cancer	0.00868	0.00925	CcSEcCtD
Terconazole—Arthralgia—Topotecan—ovarian cancer	0.00859	0.00915	CcSEcCtD
Terconazole—Myalgia—Topotecan—ovarian cancer	0.00859	0.00915	CcSEcCtD
Terconazole—Discomfort—Topotecan—ovarian cancer	0.00849	0.00904	CcSEcCtD
Terconazole—Myalgia—Melphalan—ovarian cancer	0.00841	0.00896	CcSEcCtD
Terconazole—Anaphylactic shock—Topotecan—ovarian cancer	0.00823	0.00878	CcSEcCtD
Terconazole—Anaphylactic shock—Melphalan—ovarian cancer	0.00806	0.00859	CcSEcCtD
Terconazole—Ill-defined disorder—Vinorelbine—ovarian cancer	0.00801	0.00853	CcSEcCtD
Terconazole—Pain—Chlorambucil—ovarian cancer	0.00791	0.00843	CcSEcCtD
Terconazole—Malaise—Vinorelbine—ovarian cancer	0.00778	0.00829	CcSEcCtD
Terconazole—Feeling abnormal—Chlorambucil—ovarian cancer	0.00762	0.00812	CcSEcCtD
Terconazole—Gastrointestinal pain—Chlorambucil—ovarian cancer	0.00756	0.00806	CcSEcCtD
Terconazole—Musculoskeletal discomfort—Topotecan—ovarian cancer	0.0075	0.008	CcSEcCtD
Terconazole—Influenza like illness—Epirubicin—ovarian cancer	0.00737	0.00786	CcSEcCtD
Terconazole—Toxic epidermal necrolysis—Docetaxel—ovarian cancer	0.00736	0.00784	CcSEcCtD
Terconazole—Urticaria—Chlorambucil—ovarian cancer	0.00735	0.00783	CcSEcCtD
Terconazole—Myalgia—Vinorelbine—ovarian cancer	0.00735	0.00783	CcSEcCtD
Terconazole—Arthralgia—Vinorelbine—ovarian cancer	0.00735	0.00783	CcSEcCtD
Terconazole—Musculoskeletal discomfort—Melphalan—ovarian cancer	0.00735	0.00783	CcSEcCtD
Terconazole—Body temperature increased—Chlorambucil—ovarian cancer	0.00731	0.00779	CcSEcCtD
Terconazole—Abdominal pain—Chlorambucil—ovarian cancer	0.00731	0.00779	CcSEcCtD
Terconazole—Discomfort—Vinorelbine—ovarian cancer	0.00726	0.00774	CcSEcCtD
Terconazole—Anaphylactic shock—Vinorelbine—ovarian cancer	0.00704	0.00751	CcSEcCtD
Terconazole—Pain—Topotecan—ovarian cancer	0.00704	0.0075	CcSEcCtD
Terconazole—Bronchospasm—Docetaxel—ovarian cancer	0.00695	0.0074	CcSEcCtD
Terconazole—Pain—Melphalan—ovarian cancer	0.00689	0.00735	CcSEcCtD
Terconazole—Influenza like illness—Doxorubicin—ovarian cancer	0.00682	0.00727	CcSEcCtD
Terconazole—Hypersensitivity—Chlorambucil—ovarian cancer	0.00681	0.00726	CcSEcCtD
Terconazole—Feeling abnormal—Topotecan—ovarian cancer	0.00678	0.00723	CcSEcCtD
Terconazole—Gastrointestinal pain—Topotecan—ovarian cancer	0.00673	0.00718	CcSEcCtD
Terconazole—Asthenia—Chlorambucil—ovarian cancer	0.00664	0.00707	CcSEcCtD
Terconazole—Ketoconazole—ABCB1—ovarian cancer	0.00662	0.107	CrCbGaD
Terconazole—Pruritus—Chlorambucil—ovarian cancer	0.00654	0.00697	CcSEcCtD
Terconazole—Urticaria—Topotecan—ovarian cancer	0.00654	0.00697	CcSEcCtD
Terconazole—Abdominal pain—Topotecan—ovarian cancer	0.00651	0.00694	CcSEcCtD
Terconazole—Body temperature increased—Topotecan—ovarian cancer	0.00651	0.00694	CcSEcCtD
Terconazole—Musculoskeletal discomfort—Vinorelbine—ovarian cancer	0.00642	0.00684	CcSEcCtD
Terconazole—Urticaria—Melphalan—ovarian cancer	0.0064	0.00683	CcSEcCtD
Terconazole—Hypersensitivity—Topotecan—ovarian cancer	0.00607	0.00647	CcSEcCtD
Terconazole—Pain—Vinorelbine—ovarian cancer	0.00602	0.00642	CcSEcCtD
Terconazole—Chills—Paclitaxel—ovarian cancer	0.00598	0.00638	CcSEcCtD
Terconazole—Hypersensitivity—Melphalan—ovarian cancer	0.00594	0.00633	CcSEcCtD
Terconazole—Asthenia—Topotecan—ovarian cancer	0.00591	0.0063	CcSEcCtD
Terconazole—Vomiting—Chlorambucil—ovarian cancer	0.00588	0.00627	CcSEcCtD
Terconazole—Pruritus—Topotecan—ovarian cancer	0.00583	0.00621	CcSEcCtD
Terconazole—Feeling abnormal—Vinorelbine—ovarian cancer	0.0058	0.00619	CcSEcCtD
Terconazole—Asthenia—Melphalan—ovarian cancer	0.00578	0.00617	CcSEcCtD
Terconazole—Gastrointestinal pain—Vinorelbine—ovarian cancer	0.00576	0.00614	CcSEcCtD
Terconazole—Pruritus—Melphalan—ovarian cancer	0.0057	0.00608	CcSEcCtD
Terconazole—Urticaria—Vinorelbine—ovarian cancer	0.0056	0.00596	CcSEcCtD
Terconazole—Body temperature increased—Vinorelbine—ovarian cancer	0.00557	0.00593	CcSEcCtD
Terconazole—Abdominal pain—Vinorelbine—ovarian cancer	0.00557	0.00593	CcSEcCtD
Terconazole—Nausea—Chlorambucil—ovarian cancer	0.00549	0.00586	CcSEcCtD
Terconazole—Dizziness—Topotecan—ovarian cancer	0.00544	0.0058	CcSEcCtD
Terconazole—Ill-defined disorder—Paclitaxel—ovarian cancer	0.00539	0.00574	CcSEcCtD
Terconazole—Face oedema—Epirubicin—ovarian cancer	0.00532	0.00567	CcSEcCtD
Terconazole—Vomiting—Topotecan—ovarian cancer	0.00523	0.00558	CcSEcCtD
Terconazole—Malaise—Paclitaxel—ovarian cancer	0.00523	0.00558	CcSEcCtD
Terconazole—Rash—Topotecan—ovarian cancer	0.00519	0.00553	CcSEcCtD
Terconazole—Hypersensitivity—Vinorelbine—ovarian cancer	0.00519	0.00553	CcSEcCtD
Terconazole—Dermatitis—Topotecan—ovarian cancer	0.00519	0.00553	CcSEcCtD
Terconazole—Headache—Topotecan—ovarian cancer	0.00516	0.0055	CcSEcCtD
Terconazole—Vomiting—Melphalan—ovarian cancer	0.00513	0.00546	CcSEcCtD
Terconazole—Rash—Melphalan—ovarian cancer	0.00508	0.00542	CcSEcCtD
Terconazole—Dermatitis—Melphalan—ovarian cancer	0.00508	0.00541	CcSEcCtD
Terconazole—Chills—Docetaxel—ovarian cancer	0.00507	0.00541	CcSEcCtD
Terconazole—Asthenia—Vinorelbine—ovarian cancer	0.00505	0.00539	CcSEcCtD
Terconazole—Pruritus—Vinorelbine—ovarian cancer	0.00498	0.00531	CcSEcCtD
Terconazole—Toxic epidermal necrolysis—Epirubicin—ovarian cancer	0.00496	0.00529	CcSEcCtD
Terconazole—Myalgia—Paclitaxel—ovarian cancer	0.00494	0.00527	CcSEcCtD
Terconazole—Arthralgia—Paclitaxel—ovarian cancer	0.00494	0.00527	CcSEcCtD
Terconazole—Face oedema—Doxorubicin—ovarian cancer	0.00492	0.00525	CcSEcCtD
Terconazole—Nausea—Topotecan—ovarian cancer	0.00489	0.00521	CcSEcCtD
Terconazole—Discomfort—Paclitaxel—ovarian cancer	0.00488	0.0052	CcSEcCtD
Terconazole—Nausea—Melphalan—ovarian cancer	0.00479	0.0051	CcSEcCtD
Terconazole—Anaphylactic shock—Paclitaxel—ovarian cancer	0.00474	0.00505	CcSEcCtD
Terconazole—Dizziness—Vinorelbine—ovarian cancer	0.00466	0.00496	CcSEcCtD
Terconazole—Toxic epidermal necrolysis—Doxorubicin—ovarian cancer	0.00459	0.00489	CcSEcCtD
Terconazole—Vomiting—Vinorelbine—ovarian cancer	0.00448	0.00477	CcSEcCtD
Terconazole—Rash—Vinorelbine—ovarian cancer	0.00444	0.00473	CcSEcCtD
Terconazole—Dermatitis—Vinorelbine—ovarian cancer	0.00444	0.00473	CcSEcCtD
Terconazole—Headache—Vinorelbine—ovarian cancer	0.00441	0.0047	CcSEcCtD
Terconazole—Musculoskeletal discomfort—Paclitaxel—ovarian cancer	0.00432	0.0046	CcSEcCtD
Terconazole—Arthralgia—Docetaxel—ovarian cancer	0.00419	0.00446	CcSEcCtD
Terconazole—Myalgia—Docetaxel—ovarian cancer	0.00419	0.00446	CcSEcCtD
Terconazole—Nausea—Vinorelbine—ovarian cancer	0.00418	0.00446	CcSEcCtD
Terconazole—Pain—Paclitaxel—ovarian cancer	0.00405	0.00432	CcSEcCtD
Terconazole—Anaphylactic shock—Docetaxel—ovarian cancer	0.00402	0.00428	CcSEcCtD
Terconazole—Feeling abnormal—Paclitaxel—ovarian cancer	0.0039	0.00416	CcSEcCtD
Terconazole—Gastrointestinal pain—Paclitaxel—ovarian cancer	0.00387	0.00413	CcSEcCtD
Terconazole—Urticaria—Paclitaxel—ovarian cancer	0.00376	0.00401	CcSEcCtD
Terconazole—Abdominal pain—Paclitaxel—ovarian cancer	0.00375	0.00399	CcSEcCtD
Terconazole—Body temperature increased—Paclitaxel—ovarian cancer	0.00375	0.00399	CcSEcCtD
Terconazole—Musculoskeletal discomfort—Docetaxel—ovarian cancer	0.00366	0.0039	CcSEcCtD
Terconazole—Hypersensitivity—Paclitaxel—ovarian cancer	0.00349	0.00372	CcSEcCtD
Terconazole—Pain—Docetaxel—ovarian cancer	0.00343	0.00366	CcSEcCtD
Terconazole—Chills—Epirubicin—ovarian cancer	0.00342	0.00365	CcSEcCtD
Terconazole—Asthenia—Paclitaxel—ovarian cancer	0.0034	0.00362	CcSEcCtD
Terconazole—Pruritus—Paclitaxel—ovarian cancer	0.00335	0.00357	CcSEcCtD
Terconazole—Feeling abnormal—Docetaxel—ovarian cancer	0.00331	0.00353	CcSEcCtD
Terconazole—Gastrointestinal pain—Docetaxel—ovarian cancer	0.00328	0.0035	CcSEcCtD
Terconazole—Abdominal pain—Docetaxel—ovarian cancer	0.00317	0.00338	CcSEcCtD
Terconazole—Body temperature increased—Docetaxel—ovarian cancer	0.00317	0.00338	CcSEcCtD
Terconazole—Chills—Doxorubicin—ovarian cancer	0.00316	0.00337	CcSEcCtD
Terconazole—Dizziness—Paclitaxel—ovarian cancer	0.00313	0.00334	CcSEcCtD
Terconazole—Ill-defined disorder—Epirubicin—ovarian cancer	0.00308	0.00328	CcSEcCtD
Terconazole—Vomiting—Paclitaxel—ovarian cancer	0.00301	0.00321	CcSEcCtD
Terconazole—Malaise—Epirubicin—ovarian cancer	0.00299	0.00319	CcSEcCtD
Terconazole—Rash—Paclitaxel—ovarian cancer	0.00299	0.00318	CcSEcCtD
Terconazole—Dermatitis—Paclitaxel—ovarian cancer	0.00298	0.00318	CcSEcCtD
Terconazole—Headache—Paclitaxel—ovarian cancer	0.00297	0.00316	CcSEcCtD
Terconazole—Hypersensitivity—Docetaxel—ovarian cancer	0.00296	0.00315	CcSEcCtD
Terconazole—Asthenia—Docetaxel—ovarian cancer	0.00288	0.00307	CcSEcCtD
Terconazole—Ill-defined disorder—Doxorubicin—ovarian cancer	0.00285	0.00304	CcSEcCtD
Terconazole—Pruritus—Docetaxel—ovarian cancer	0.00284	0.00303	CcSEcCtD
Terconazole—Arthralgia—Epirubicin—ovarian cancer	0.00283	0.00301	CcSEcCtD
Terconazole—Myalgia—Epirubicin—ovarian cancer	0.00283	0.00301	CcSEcCtD
Terconazole—Nausea—Paclitaxel—ovarian cancer	0.00281	0.003	CcSEcCtD
Terconazole—Discomfort—Epirubicin—ovarian cancer	0.00279	0.00298	CcSEcCtD
Terconazole—Malaise—Doxorubicin—ovarian cancer	0.00277	0.00295	CcSEcCtD
Terconazole—Anaphylactic shock—Epirubicin—ovarian cancer	0.00271	0.00289	CcSEcCtD
Terconazole—Dizziness—Docetaxel—ovarian cancer	0.00266	0.00283	CcSEcCtD
Terconazole—Arthralgia—Doxorubicin—ovarian cancer	0.00261	0.00279	CcSEcCtD
Terconazole—Myalgia—Doxorubicin—ovarian cancer	0.00261	0.00279	CcSEcCtD
Terconazole—Discomfort—Doxorubicin—ovarian cancer	0.00258	0.00275	CcSEcCtD
Terconazole—Vomiting—Docetaxel—ovarian cancer	0.00255	0.00272	CcSEcCtD
Terconazole—Rash—Docetaxel—ovarian cancer	0.00253	0.0027	CcSEcCtD
Terconazole—Dermatitis—Docetaxel—ovarian cancer	0.00253	0.0027	CcSEcCtD
Terconazole—Headache—Docetaxel—ovarian cancer	0.00252	0.00268	CcSEcCtD
Terconazole—Anaphylactic shock—Doxorubicin—ovarian cancer	0.00251	0.00267	CcSEcCtD
Terconazole—Musculoskeletal discomfort—Epirubicin—ovarian cancer	0.00247	0.00263	CcSEcCtD
Terconazole—Nausea—Docetaxel—ovarian cancer	0.00239	0.00254	CcSEcCtD
Terconazole—Pain—Epirubicin—ovarian cancer	0.00232	0.00247	CcSEcCtD
Terconazole—Musculoskeletal discomfort—Doxorubicin—ovarian cancer	0.00228	0.00243	CcSEcCtD
Terconazole—Feeling abnormal—Epirubicin—ovarian cancer	0.00223	0.00238	CcSEcCtD
Terconazole—Gastrointestinal pain—Epirubicin—ovarian cancer	0.00221	0.00236	CcSEcCtD
Terconazole—Urticaria—Epirubicin—ovarian cancer	0.00215	0.00229	CcSEcCtD
Terconazole—Pain—Doxorubicin—ovarian cancer	0.00214	0.00228	CcSEcCtD
Terconazole—Abdominal pain—Epirubicin—ovarian cancer	0.00214	0.00228	CcSEcCtD
Terconazole—Body temperature increased—Epirubicin—ovarian cancer	0.00214	0.00228	CcSEcCtD
Terconazole—Feeling abnormal—Doxorubicin—ovarian cancer	0.00207	0.0022	CcSEcCtD
Terconazole—Gastrointestinal pain—Doxorubicin—ovarian cancer	0.00205	0.00218	CcSEcCtD
Terconazole—Hypersensitivity—Epirubicin—ovarian cancer	0.002	0.00213	CcSEcCtD
Terconazole—Urticaria—Doxorubicin—ovarian cancer	0.00199	0.00212	CcSEcCtD
Terconazole—Body temperature increased—Doxorubicin—ovarian cancer	0.00198	0.00211	CcSEcCtD
Terconazole—Abdominal pain—Doxorubicin—ovarian cancer	0.00198	0.00211	CcSEcCtD
Terconazole—Asthenia—Epirubicin—ovarian cancer	0.00194	0.00207	CcSEcCtD
Terconazole—Pruritus—Epirubicin—ovarian cancer	0.00192	0.00204	CcSEcCtD
Terconazole—Hypersensitivity—Doxorubicin—ovarian cancer	0.00185	0.00197	CcSEcCtD
Terconazole—Asthenia—Doxorubicin—ovarian cancer	0.0018	0.00192	CcSEcCtD
Terconazole—Dizziness—Epirubicin—ovarian cancer	0.00179	0.00191	CcSEcCtD
Terconazole—Pruritus—Doxorubicin—ovarian cancer	0.00177	0.00189	CcSEcCtD
Terconazole—Vomiting—Epirubicin—ovarian cancer	0.00172	0.00184	CcSEcCtD
Terconazole—Rash—Epirubicin—ovarian cancer	0.00171	0.00182	CcSEcCtD
Terconazole—Dermatitis—Epirubicin—ovarian cancer	0.00171	0.00182	CcSEcCtD
Terconazole—Headache—Epirubicin—ovarian cancer	0.0017	0.00181	CcSEcCtD
Terconazole—Dizziness—Doxorubicin—ovarian cancer	0.00166	0.00177	CcSEcCtD
Terconazole—Nausea—Epirubicin—ovarian cancer	0.00161	0.00171	CcSEcCtD
Terconazole—Vomiting—Doxorubicin—ovarian cancer	0.00159	0.0017	CcSEcCtD
Terconazole—Rash—Doxorubicin—ovarian cancer	0.00158	0.00168	CcSEcCtD
Terconazole—Dermatitis—Doxorubicin—ovarian cancer	0.00158	0.00168	CcSEcCtD
Terconazole—Headache—Doxorubicin—ovarian cancer	0.00157	0.00167	CcSEcCtD
Terconazole—Nausea—Doxorubicin—ovarian cancer	0.00149	0.00159	CcSEcCtD
